|
|
Vol. 15.22 – 15 July, 2024
|
|
|
|
|
|
|
|
The authors used human induced pluripotent stem cells (iPSCs) to produce natural killer (NK) cells engineered to mediate improved anti-HCC activity. [Cell Stem Cell]
|
|
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal
|
|
|
|
|
|
Scientists demonstrated that genetic deletion of the adhesion ligands CD54 and CD58 in B2M-deficient CAR T cells and multi-edited induced pluripotent stem cell-derived CAR NK cells reduced their susceptibility to rejection by host NK cells in vitro and in vivo.
[Cell Stem Cell]
|
|
|
|
|
|
The authors fabricated an exercise self-powered triboelectric-responsive microneedle assay with the sustainable release of optogenetically engineered extracellular vesicles for intervertebral disc degeneration repair.
[Nature Communications]
|
|
|
|
|
|
Researchers demonstrated that the expression of a CAR targeting CD5, a prominent pan-T cell antigen, induced rapid internalization and complete loss of the CD5 protein on T cells, protecting them from self-targeting.
[Cell Reports Medicine]
|
|
|
|
|
|
Cytokine-induced memory–like NK cells demonstrated superior antitumor responses against a panel of epithelial ovarian cancer cell lines, increased expression of activation receptors, and up-regulation of genes involved in cell cycle/proliferation and down-regulation of inhibitory/suppressive genes.
[Science Advances]
|
|
|
|
|
|
Investigators engineered a single-chain, bispecific CAR targeting IL-13Rα2 and TGF-β, which programmed tumor-specific T cells to convert TGF-β from an immunosuppressant to an immunostimulant.
[Neuro-Oncology]
|
|
|
|
|
|
Molecular characterization captured vector integration sites and CRISPR editing signatures and functional studies, including in vivo potency studies in humanised mice, confirmed antileukaemic activity comparable to peripheral blood-derived universal CAR19 T cells.
[Haematologica]
|
|
|
|
|
|
Scientists compared the efficacy of autologous hematopoietic cell transplantation (auto-HCT) vs. CAR-T in patients with DLBCL in complete remission. A retrospective observational study comparing auto-HCT (2015–2021) vs. CAR-T using the Center for International Blood & Marrow Transplant Research registry.
[Blood Cancer Journal]
|
|
|
|
|
|
Researchers utilized subcutaneous tumor models in nude mice to assess gastric cancer progression. Protein expression was detected using Western blotting, while qPCR examined the expression levels of lncRNA SNHG18 and miR-211-5p in MGC-803 cells. [Heliyon]
|
|
|
|
|
|
|
|
The authors present an overview of the current landscape of gene therapies, focusing on clinical research and gene therapy products for inherited blood disorders, evaluation of potential gene targets, and the gene editing tools employed in current gene therapy practices. [Journal of Genetics and Genomics]
|
|
|
|
|
|
|
|
The Tanoto Foundation pledged $5 million to The University of Texas MD Anderson Cancer Center to support cell therapy discovery and innovation research. [MD Anderson Cancer Center]
|
|
|
|
|
|
A Bucknell University professor has received nearly $200,000 in grant funding to research therapeutic applications of ultrasound and the expansion of regenerative medicine education for underrepresented college and high school students. [The Daily Item]
|
|
|
|
|
|
|
|
August 19 – 21, 2024 San Diego, California, United States
|
|
|
|
|
|
|
|
|
|
|
ElevateBio – Waltham, Massachusetts, United States
|
|
|
|
|
|
|
University of British Columbia – Vancouver, British Columbia, Canada
|
|
|
|
|
|
|
City of Hope – Duarte, California, United States
|
|
|
|
|
|
|
Baylor College of Medicine – Houston, Texas, United States
|
|
|
|
|
|
|
Goethe University Frankfurt am Main – Frankfurt, Germany
|
|
|
|
|
|